Literature DB >> 21498292

Ischemic liver injuries after hepatic artery embolization in patients with delayed postoperative hemorrhage following hepatobiliary pancreatic surgery.

Sung Ki Cho1, Sam Soo Kim, Young Soo Do, Kwang Bo Park, Sung Wook Shin, Hong Suk Park, Sung Wook Choo, In Wook Choo.   

Abstract

BACKGROUND: Many collateral pathways to the liver are dissected during hepatobiliary pancreatic surgery and, if the arterial bleeding is massive and a hematoma becomes larger, the adjacent portal vein can be compressed with impairment of the portal venous flow.
PURPOSE: To evaluate the frequency and severity of ischemic liver injuries after hepatic artery embolization in patients with delayed postoperative arterial hemorrhage after hepatobiliary pancreatic surgery.
MATERIAL AND METHODS: Eighteen patients undergoing proper or common hepatic artery embolization for delayed postoperative arterial hemorrhage after hepatobiliary pancreatic surgery achieved hemostasis. To evaluate the frequency and severity of ischemic liver injuries, the liver enzyme levels and CT findings before and after hepatic artery embolization were retrospectively compared and the clinical outcomes after hepatic artery embolization were analyzed. Angiographic findings were also analyzed to reveal any association with development of ischemic liver injuries after hepatic artery embolization.
RESULTS: Ischemic liver injuries were observed in 15 (83%) of 18 patients undergoing hepatic artery embolization for postoperative hemorrhage. Injuries included hepatic infarction combined with abscess in one (5%) patient, hepatic infarction in 12 (67%) patients, and transient hepatic ischemia/dysfunction in two (11%). As for the extent of hepatic infarction, lobar infarction developed in two patients and subsegmental infarction in 11. One patient with right hepatic lobar infarction died of hepatic failure 11 days after hepatic artery embolization. In the other 14 patients with ischemic liver injuries, the elevated liver enzymes returned to baseline levels within two weeks. All of the four patients with portal vein stenosis, four patients with no hepatic arterial flow on post-embolization angiogram, and one patient with both had hepatic infarction after hepatic artery embolization. No ischemic liver injuries developed after hepatic artery embolization in three patients with no portal vein stenosis and bilobar hepatic arterial flow via the left hepatic artery aberrantly arising from the left gastric artery or from the common hepatic artery.
CONCLUSION: Ischemic liver injuries can develop in most patients undergoing hepatic artery embolization for postoperative arterial hemorrhage after hepatobiliary pancreatic surgery; hepatic infarction appears to be the most frequent type of ischemic liver injury. Hepatic artery embolization for postoperative arterial hemorrhage after hepatobiliary pancreatic surgery may carry a great risk of ischemic liver injury if a patient has portal vein stenosis or no aberrant hepatic artery.

Entities:  

Mesh:

Year:  2011        PMID: 21498292     DOI: 10.1258/ar.2011.100414

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  9 in total

1.  The vascular anatomy of the ligaments of the liver: gross anatomy, imaging and clinical applications.

Authors:  Kenji Ibukuro; Hozumi Fukuda; Kimiko Tobe; Keiichi Akita; Takaya Takeguchi
Journal:  Br J Radiol       Date:  2016-05-10       Impact factor: 3.039

2.  Anomalous arterial ramification in the right liver.

Authors:  Takanori Sakaguchi; Shohachi Suzuki; Takanori Hiraide; Yasushi Shibasaki; Yoshifumi Morita; Atsushi Suzuki; Kazuhiko Fukumoto; Keisuke Inaba; Yasuo Takehara; Hatsuko Nasu; Mika Kamiya; Shuhei Yamashita; Takasuke Ushio; Hiroyuki Konno
Journal:  Surg Today       Date:  2012-11-23       Impact factor: 2.549

3.  Ischemic Liver Injury After Complete Occlusion of Hepatic Artery in the Treatment of Delayed Postoperative Arterial Bleeding.

Authors:  Ji Zhang; Hong-gang Qian; Jia-hua Leng; Hui Qiu; Jian-hui Wu; Bo-nan Liu; Cheng-peng Li; Meng Wei; Qiao Liu; Ang Lv; Chun-yi Hao
Journal:  J Gastrointest Surg       Date:  2015-09-02       Impact factor: 3.452

4.  Post-pancreaticoduodenectomy hemorrhage: DSA diagnosis and endovascular treatment.

Authors:  Tan-Yang Zhou; Jun-Hui Sun; Yue-Lin Zhang; Guan-Hui Zhou; Chun-Hui Nie; Tong-Yin Zhu; Sheng-Qun Chen; Bao-Quan Wang; Wei-Lin Wang; Shu-Sen Zheng
Journal:  Oncotarget       Date:  2017-04-27

5.  Liver necrosis shortly after pancreaticoduodenectomy with resection of the replaced left hepatic artery.

Authors:  Michihiro Yamamoto; Masazumi Zaima; Hidekazu Yamamoto; Hideki Harada; Junichiro Kawamura; Masahiro Yamada; Tekefumi Yazawa; Junya Kawasoe
Journal:  World J Surg Oncol       Date:  2017-04-11       Impact factor: 2.754

6.  Risk Factors for In-hospital Mortality After Transarterial Intervention After Postpancreatectomy Hemorrhage.

Authors:  Steffen Wolk; Christoph Georg Radosa; Marius Distler; Hanns-Christoph Held; Jens-Peter Kühn; Jürgen Weitz; Thilo Welsch; Ralf-Thorsten Hoffmann
Journal:  Cardiovasc Intervent Radiol       Date:  2020-05-20       Impact factor: 2.740

Review 7.  Unsuccessful Stent Graft Repair of a Hepatic Artery Aneurysm Presenting with Haemobilia: Case Report and Comprehensive Literature Review.

Authors:  Xing Gao; Jeroen de Jonge; Hence Verhagen; Wouter Dinkelaar; Sander Ten Raa; Marie Josee van Rijn
Journal:  EJVES Vasc Forum       Date:  2021-06-26

8.  Efficacy and safety of endovascular therapy for delayed hepatic artery post-pancreatectomy hemorrhage: development of extrahepatic collateral circulation and complications of post endovascular therapy.

Authors:  Yosuke Nozawa; Shinji Ymazoe; Koichi Masuda; Yutaka Takigawa; Yuko Kobashi; Koshi Ikeda; Takeshi Fukuda; Kenkichi Michimoto
Journal:  CVIR Endovasc       Date:  2022-09-05

9.  Complete embolisation of the proper hepatic artery for delayed haemorrhage after pancreaticoduodenectomy: a case report.

Authors:  Youwei Wu; Junlong Dai; Junyi Shen; Xiaoyun Zhang; Wei Peng; Chuan Li; Tianfu Wen
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.